StimOxyGen secures £1.5m to advance breakthrough therapy overcoming cancer… | DSW Ventures

other

▤ Summary

This Ulster University spin-out is tackling aggressive cancers by increasing the effectiveness of treatment. Stims technology delivers oxygen directly to tumours, making them much more responsive to existing therapies. This is hugely important because hypoxia contributes to 80-90% of cancer-related deaths due to treatment resistance. Led by CEO Sian Farrell and an experienced team including Chair Sam Rothstein, StimOxyGen is now well funded to progress this groundbreaking technology. Read the full story: https://lnkd.in/eYDX5BYH #DSWVentures #CancerTherapy #Biotech #Investment #UlsterUniversity #SpinOut #Innovation #MedicalTechnology

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies

Refresh Inc.
$1M to $5M